| Literature DB >> 20562092 |
Stephen James Gentles1, Cynthia Lokker, K Ann McKibbon.
Abstract
BACKGROUND: Pediatric patients with health conditions requiring follow-up typically depend on a caregiver to mediate at least part of the necessary two-way communication with health care providers on their behalf. Health information technology (HIT) and its subset, information communication technology (ICT), are increasingly being applied to facilitate communication between health care provider and caregiver in these situations. Awareness of the extent and nature of published research involving HIT interventions used in this way is currently lacking.Entities:
Mesh:
Year: 2010 PMID: 20562092 PMCID: PMC2956233 DOI: 10.2196/jmir.1390
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Iterative eligibility criteria
| Exclusion Criteria | Inclusion Criteria | |
| First screen | Telephone or email was used for survey or trial recruitment purposes | Electronic health records that allow access by caregivers |
| Acute diseases and other conditions not requiring follow-up, including vaccinations | Patient or caregiver use of HIT in settings other than the home, including emergency departments (EDs) or health care provider offices | |
| HIT used for epidemiological or public health purposes | ||
| Telemedicine applications where communication was entirely among health care providers | ||
| Prenatal patients | ||
| Second screen | No communication that involved both caregiver and health care provider | Telephone triage services |
| No electronic technology used to communicate | Computer kiosks in health care settings | |
| Communication while parties were face-to-face | ||
| Third screen | Telephone triage services not explicitly dedicated to chronic diseases or conditions requiring follow-up | Studies of healthy patients, provided the HIT intervention was intended for chronic disease |
| Large programs of which telephone was only a small element |
Definitions of the research phases adapted from the MRC guideline for complex interventions [16] used to classify studies
| Research Phase | Definition |
| Development phase | Studies in the development phase are those that investigate intervention design-related outcomes (satisfaction, feasibility, usability) before the intervention has reached a deployable state of development. Also included are theoretical and modeling studies or reports limited to describing the technology or user interactions with it. |
| Piloting phase | Studies in the piloting phase are those that investigate intervention design-related outcomes when it is a question of refining the intervention after it has reached a relatively complete stage of development. User-related outcomes (behavior change, resource use, clinical outcomes, quality of life) are often measured in the same study. Feasibility and pilot studies that feature user-related measures are differentiated from full-scale evaluations (below) if their outcomes are less important (eg, process outcomes), sample size is small, or a less rigorous study design is used. Some studies reported the adaptation of an existing technology (eg, video-conferencing for telemedicine) for a particular disease, using a case study format where patient outcomes are described. Although these studies do not involve a program of development, they were categorized as feasibility and piloting studies because they report user-related outcomes. |
| Evaluation phase | Studies in the evaluation phase are those that evaluate important user-related outcomes that use one of the more rigorous available study design options and have a large sample size. |
| Implementation phase | Studies in the implementation phase are those that evaluate user-related outcomes for an intervention that is well established (eg, in use for more than 2 years) or for which a full-scale evaluation has been published. As many implementation efforts are not reported, it was expected that this phase would have low representation. |
Figure 1Search and screening results
Proportional distribution (percent) of studies by disease and country (N = 104)
| Total | United | Australia | Canada | United | Italy | Otherb | |
| (n) % | (n) % | (n) % | (n) % | (n) % | (n) % | (n) % | |
| (104) 100 | (53) 51 | (15) 14 | (12) 12 | (6) 6 | (4) 4 | (14) 13 | |
| Asthma [ | (18) 17 | (12) 12 | (2) 2 | - | - | - | (4) 4 |
| Type 1 diabetes [ | (12) 12 | (6) 6 | - | - | (1) 1 | (1) 1 | (4) 4 |
| Special needs [ | (11) 11 | (7) 7 | (1) 1 | - | (1) 1 | (1) 1 | (1) 1 |
| Psychiatric disorder [ | (10) 10 | (4) 4 | (1) 1 | (2) 2 | 1 | - | - |
| Various diseases [ | (7) 7 | (5) 5 | (1) 1 | - | - | - | (1) 1 |
| Cancer [ | (5) 5 | (2) 2 | (3) 3 | - | - | - | - |
| Cardiac disorder [ | (4) 4 | - | - | (1) 1 | (3) 3 | - | - |
| Sudden infant death syndrome risk [ | (4) 4 | (3) 3 | - | - | - | - | (1) 1 |
| Burns [ | (3) 3 | - | (2) 2 | - | - | - | (1) 1 |
| Complex health care needs post-discharge [ | (3) 3 | - | - | (3) 3 | - | - | - |
| Speech-language pathology [ | (3) 3 | (1) 1 | (1) 1 | (1) 1 | - | - | - |
| Chronic kidney disease (dialysis) [ | (2) 2 | - | - | - | - | (2) 2 | - |
| Cystic fibrosis [ | (2) 2 | (1) 1 | (1) 1 | - | - | - | - |
| Epilepsy [ | (2) 2 | (2) 2 | - | - | - | - | - |
| Traumatic brain injury [ | (2) 2 | (2) 2 | - | - | - | - | - |
| Very low birth weight [ | (2) 2 | (2) 2 | - | - | - | - | - |
| Othera | (14) 13 | (6) 6 | (1) 1 | (5) 5 | - | - | (2) 2 |
a Diseases that were the topic of only 1 study that met the inclusion criteria: Anorexia nervosa (Canada) [110], endocrine (Australia) [111], feeding disorders (United States) [112], gastroenterological (United States) [113], hemophilia (Canada) [114], HIV (United States) [115], hypertension (Greece) [116], medical and surgical problems (Canada) [117], recurrent pain (Canada) [118], respiratory failure (Japan) [119], rheumatological disease (United States) [7], scoliosis (Canada) [120], sickle cell anemia (United States) [121], vascular infusion (United States) [122].
b Countries from which only 1 or 2 studies met the inclusion criteria: Germany (2; SIDS, diabetes), Netherlands (2; asthma), Norway (2; burns, diabetes), France (1; diabetes), Greece (1; hypertension), Ireland (1; special needs), Israel (1; asthma), Japan (1; respiratory failure), Multiple (1; type 1 diabetes), Spain (1; various), Taiwan (1; asthma).
Percent of studies with selected participant characteristics (N = 104)
| Characteristic | (n) % | |
| 0-24 months | (41) 39 | |
| 2-6 years | (63) 61 | |
| 6-12 years | (83) 80 | |
| 13-18 years | (70) 67 | |
| Home | (74) 71 | |
| Communitya | (11) 11 | |
| Clinical | (29) 28 | |
| Nurse | (38) 37 | |
| Therapistb | (25) 24 | |
| Primary care physician | (19) 18 | |
| Sub-specialist | (65) 63 | |
| Public health | (3) 3 | |
| Primary care | (10) 10 | |
| Hospitalc | (96) 92 | |
| Other | (2) 2 | |
a Community settings include school or daycare.
b Therapists include psychologists or counselors.
c Hospital settings include specialty clinics; other settings include call centers or home care.
Percent of studies with selected intervention characteristics (N = 104)
| Intervention Characteristic | (n) % | |
| Interneta | (34) 33 | |
| Intraneta | (6) 6 | |
| Telephone | (26) 25 | |
| Video conference | (46) 44 | |
| (22) 21 | ||
| SMS | (3) 3 | |
| Manual download | (13) 13 | |
| Text | (36) 35 | |
| Voice | (53) 51 | |
| Video or imaging | (50) 48 | |
| Multimedia | (18) 17 | |
| Binary | (30) 29 | |
| Caregiver psychological support | (34) 33 | |
| Patient psychological support | (17) 16 | |
| Physiological monitoring | (40) 38 | |
| Behavioral surveillance | (16) 15 | |
| Diagnosis | (36) 35 | |
| Medication management | (49) 47 | |
| Physical care management | (18) 17 | |
| Patient behavior management | (33) 32 | |
| Professional counseling | (33) 32 | |
| Medical consultation | (47) 45 | |
| Mental health tx (non-counseling) | (15) 14 | |
| Education | (41) 39 | |
| Referral | (13) 13 | |
| Transfer patient data to family | (16) 15 | |
| Virtual family visits | (4) 4 | |
a Internet and intranet modes generally excluded telephone, video conference, and email.
Percent of studies measuring selected outcomes (N = 104)
| Type of Outcome | Overall | Patient | Caregiver | Health Care Provider | Program Level | |
| (n) % | (n) % | (n) % | (n) % | (n) % | ||
| Satisfaction | (60) 58 | (33) 32 | (58) 56 | (19) 18 | - | |
| Feasibility | (70) 67 | (20) 19 | (34) 33 | (23) 22 | (45) 43 | |
| Usability | (39) 38 | (23) 22 | (35) 34 | (14) 13 | - | |
| Usage | (21) 20 | (9) 9 | (16) 15 | (6) 6 | (8) 8 | |
| Behavior change | (24) 23 | (18) 17 | (16) 15 | (5) 5 | - | |
| Resource use | (26) 25 | (18) 17 | (8) 8 | (5) 5 | (12) 12 | |
| Knowledge | (10) 10 | (9) 9 | (10) 10 | - | - | |
| Clinical outcomes | (33) 32 | (31) 30 | (2) 2 | - | - | |
| Quality of life | (21) 20 | (17) 16 | (13) 13 | - | - | |
Common themes or problems addressed by HIT interventions
| Theme | Description | Example Disease Contexts |
| Establishing continuity of care | Extending care to patients in the community (home, school) beyond settings where they traditionally access care (eg, hospitals) | Complex health care needs post-discharge from hospital |
| Addressing time constraints | Increasing efficiency of care or reducing time burden on health care providers | ED decision support for asthma |
| Bridging geographical barriers | Reducing the need for patient travel or providing access to distant specialists | Burn care to patients in rural Australia |